LEO Pharma: latest news - GoINPHARMA
Monday, 10 December 2018 - 15:08

LEO Pharma

Bayer sells dermatology unit to Leo Pharma

Denmark-based Leo Pharma yesterday announced it had acquired Bayer’s dermatology unit. The acquisition covers a series of prescription products for the treatment of skin diseases such as acne (Skinoren), fungal infections (Travogen) and a significant number of topical steroid preparations…

Leo Pharma sells 10 products to Karo Pharma for €260m

Denmark-based Leo Pharma has announced today it has sold the rights to ten products to its Sweden-based competitor Karo Pharma for €260m. The transaction only includes rights, not production sites or R&D staff. The divested brands include Conotrane®, Fonx®, Condyline®,…

JV between Leo Pharma and Klox Technologies

Canada-based Klox Technologies and Danish multinational Leo Pharma AS announced today they have created a JV in order to develop and commercialize novel and already existent products based on Klox’s Bio-Photonic portfolio, including Kleresca® for acne and Kleresca®. The new…